ResolvedStocks

MeiraGTx Stock Hits 52-Week High Ahead of Pivotal Gene Therapy Data

First Detected: Apr 15, 2026, 11:42 PM

Last Update: 5 months ago

144 articles·44 stories

Event Summary

On April 15, MeiraGTx stock reached a 52-week high ahead of the pivotal Phase 1 data readout for AAV-hAQP1, aimed at treating radiation-induced xerostomia. Estimated peak sales for AAV2hAQP1 are approximately $1.2 billion.

Timeline

Mixed US Stock Movements as AI Infrastructure Surges While Cybersecurity Faces Pressure

Apr 16, 2026, 11:17 PMImpact: 6

Abbott Acquires Exact Sciences for $23 Billion in Major Diagnostics Deal

Apr 16, 2026, 8:17 PMImpact: 8

Whitefort Capital Discloses 8.1% Stake in Arbutus Biopharma

Apr 16, 2026, 8:03 PMImpact: 5

TG Therapeutics Completes Enrollment for Phase 3 Subcutaneous BRIUMVI Trial

Apr 16, 2026, 6:15 AMImpact: 5

Goldman Sachs and UBS Raise Nextracker (NXT) Price Targets Following Earnings Beats

Apr 16, 2026, 5:32 AMImpact: 6

Crypto Market Gains Momentum as Bitcoin and Ethereum Eye Key Breakout Levels

Apr 16, 2026, 5:17 AMImpact: 4

Poolbeg Pharma Shares Surge on UK MHRA Clearance for POLB 001 Study

Apr 16, 2026, 5:03 AMImpact: 6

Undervalued Telecom Stocks Gain Focus as MeiraGTx Hits 52-Week High

Apr 16, 2026, 5:02 AMImpact: 4

Precision BioSciences Receives Approval to Expand Hepatitis B Clinical Trials in Europe

Apr 16, 2026, 4:31 AMImpact: 5

Catalyst Pharmaceuticals Surges 148% on Strong Institutional Inflows

Apr 16, 2026, 4:30 AMImpact: 4

Clearmind Medicine Receives Positive DSMB Recommendation for CMND-100 Clinical Trial

Apr 16, 2026, 4:30 AMImpact: 4

Medicus Pharma to Present Promising Teverelix Clinical Data at AACE 2026

Apr 16, 2026, 4:17 AMImpact: 4

Achieve Life Sciences Strengthens U.S. Manufacturing Capabilities Ahead of Drug Launch

Apr 16, 2026, 4:16 AMImpact: 4

Institutional Inflows Drive Carpenter Technology Shares 1,695% Higher Since 2005

Apr 16, 2026, 4:15 AMImpact: 4

FDA Accepts NorthStar Medical’s Drug Master File for Actinium-225 Production

Apr 16, 2026, 4:15 AMImpact: 6

Small-Cap Resource Firms Secure Capital via Private Placements to Fund Operations

Apr 16, 2026, 4:03 AMImpact: 4

Stock Performance Divergence: ADMA Plunges as Kinross Gold Surges on Record Prices

Apr 16, 2026, 4:01 AMImpact: 4

Lunai Bioworks Enters Defense Sector with Chemical Threat Assessment Deal

Apr 16, 2026, 3:32 AMImpact: 5

Mixed Outlook for Adagene and Lantheus as FDA Extends OCTEVY Review Timeline

Apr 16, 2026, 3:31 AMImpact: 6

Daiichi Sankyo and Wayfinder Biosciences Advance Neurodegeneration Research to Phase 2

Apr 16, 2026, 3:15 AMImpact: 4

GitLab Shares Surge 5.5% on Expanded Strategic Partnership with Google Cloud

Apr 16, 2026, 3:03 AMImpact: 6

Netflix Shares Slide Despite Q1 Beat as Alcoa and Knight-Swift Post Weak Results

Apr 16, 2026, 2:46 AMImpact: 4

Merck Q1 Earnings Outlook Bolstered by Keytruda Sales Growth

Apr 16, 2026, 2:45 AMImpact: 4

Curtiss-Wright and Avnet Hit 52-Week Highs Amid Defense and Tech Momentum

Apr 16, 2026, 2:33 AMImpact: 4

Global Markets Mixed as Leisure Strength Battles Geopolitical Tensions

Apr 16, 2026, 2:02 AMImpact: 4

Simulations Plus Reports 8% Q2 Revenue Growth Amid Neutral Analyst Outlook

Apr 16, 2026, 1:01 AMImpact: 4

BioMarin Stock Seen as Buy Opportunity After 12% Drop and Amicus Integration

Apr 16, 2026, 12:47 AMImpact: 4

SAB Biotherapeutics Eyes Key Milestones for Type 1 Diabetes Treatment

Apr 16, 2026, 12:33 AMImpact: 4

ONWARD Medical Launches EUR 40 Million Capital Increase

Apr 16, 2026, 12:17 AMImpact: 6

US Market Rally Broadens as Russell 2000 Hits New Record Highs

Apr 16, 2026, 12:01 AMImpact: 4

Niagen Bioscience Pivots to Telehealth Model to Drive Higher Margins

Apr 15, 2026, 11:48 PMImpact: 4

Axsome Therapeutics Nears Buy Point Amid $2 Billion Market Opportunity

Apr 15, 2026, 11:42 PMImpact: 7

MeiraGTx Stock Hits 52-Week High Ahead of Pivotal Gene Therapy Data

Event Summary

Timeline

Price Impact